Video Experimental Relacionado
Updated: Jul 22, 2025
09:01
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
7.9K
Vacuna contra el virus sincitial respiratorio Prefusión F
Ann R Falsey1, Edward E Walsh1
1Department of Medicine, University of Rochester, Rochester, NY, USA.
Cell
|July 21, 2023
Resumen
El virus sincitial respiratorio (VSR) causa infecciones respiratorias graves en los niños y reinfecciones en los adultos. La estabilización de la glicoproteína F del RSV en su forma de prefusión fue clave para desarrollar vacunas efectivas para adultos mayores.
Área de la Ciencia:
- Virología
- Vacunas y vacunas
- Inmunología
Sus antecedentes:
- El virus sincitial respiratorio (VSR) es una de las principales causas de enfermedades respiratorias graves en los lactantes.
- Las infecciones por RSV también son comunes en adultos mayores, lo que lleva a una morbilidad significativa.
- Desarrollar vacunas efectivas contra el VSR ha sido un desafío de larga data durante décadas.
Objetivo del estudio:
- Para resaltar el papel crítico de estabilizar la conformación de prefusión de la glicoproteína F del RSV.
- Explicar cómo esta estabilización permite el desarrollo de vacunas eficaces.
- Proporcionar información sobre el viaje del "banco al lado de la cama" del desarrollo de la vacuna contra el RSV.
Principales métodos:
- Se centra en la estabilización estructural de la glicoproteína F del virus sincitial respiratorio (VSR).
- Utiliza avances en biología estructural para capturar la conformación de la prefusión.
- Detalla las implicaciones para el diseño y la eficacia de la vacuna.
Principales resultados:
- Estabilización exitosa de la glicoproteína F del RSV en su estado de prefusión.
- Este avance estructural es esencial para obtener una respuesta inmune protectora.
- allanó el camino para el desarrollo de nuevas vacunas contra el RSV.
Conclusiones:
- La estabilización de la conformación de prefusión de la glicoproteína F del RSV fue un avance crítico.
- Este logro es fundamental para crear vacunas efectivas contra el RSV, especialmente para las poblaciones vulnerables como los adultos mayores.
- Representa un hito significativo en la lucha contra las infecciones respiratorias relacionadas con el RSV.
Videos de Conceptos Relacionados
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
01:21Acute Respiratory Failure-I
250
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
250
01:29Acute Respiratory Failure-V
165
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
165
01:31Common Respiratory Disorders
694
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
694
01:21Acute Respiratory Failure-II
278
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278